{"entities":{"Q100708":{"pageid":102027,"ns":120,"title":"Item:Q100708","lastrevid":84645011,"modified":"2026-05-28T08:22:55Z","type":"item","id":"Q100708","labels":{"en":{"language":"en","value":"Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials"}},"descriptions":{"en":{"language":"en","value":"scientific article"}},"aliases":{},"claims":{"P31":[{"mainsnak":{"snaktype":"value","property":"P31","hash":"fd5912e4dab4b881a8eb0eb27e7893fef55176ad","datavalue":{"value":{"entity-type":"item","numeric-id":56887,"id":"Q56887"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q100708$7EEC4AF1-BBB7-4721-8EA8-A50BA93D39AB","rank":"normal"}],"P200":[{"mainsnak":{"snaktype":"value","property":"P200","hash":"90d7cf0f01d87fadc1672c233a23b31df268de2e","datavalue":{"value":{"entity-type":"item","numeric-id":71902,"id":"Q71902"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q100708$1943A58B-374F-4200-991F-B42D56441359","rank":"normal"}],"P26":[{"mainsnak":{"snaktype":"value","property":"P26","hash":"44dc7c2dfe563f865c069079f99e746133e1f927","datavalue":{"value":"23","type":"string"},"datatype":"string"},"type":"statement","id":"Q100708$7526CD56-58C8-4AE4-8BC8-36250AF6ECA1","rank":"normal"}],"P25":[{"mainsnak":{"snaktype":"value","property":"P25","hash":"68b47585e633a4a2b067e511536f1dd047cbde8f","datavalue":{"value":"1","type":"string"},"datatype":"string"},"type":"statement","id":"Q100708$BB7918E8-852E-44C9-AB4D-D65017700419","rank":"normal"}],"P128":[{"mainsnak":{"snaktype":"value","property":"P128","hash":"ac76c71a4d43c0a00644dc6db7833cb9e15ddc6f","datavalue":{"value":"13-20","type":"string"},"datatype":"string"},"type":"statement","id":"Q100708$CEAA660A-F5C7-4A4E-BE59-A5209077264F","rank":"normal"}],"P28":[{"mainsnak":{"snaktype":"value","property":"P28","hash":"6c9d2ae3d0c1afb3b001693101ae63b1db6ef1c3","datavalue":{"value":{"time":"+2017-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":11,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q100708$1E6EDCD3-0EA6-4667-8A16-462EEB479508","rank":"normal"}],"P1460":[{"mainsnak":{"snaktype":"value","property":"P1460","hash":"57f7fea50d2ce1b39b695c4a1313582eed405e38","datavalue":{"value":{"entity-type":"item","numeric-id":5976449,"id":"Q5976449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q100708$8969F2D0-6EC9-464C-AAAB-B1D80EEDC88B","rank":"normal"}],"P12":[{"mainsnak":{"snaktype":"value","property":"P12","hash":"e179f8473aee6567076d92b01798c3adb1cfb762","datavalue":{"value":"Q50039167","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q100708$9825F87A-1129-4FE6-B3AE-B91AE61CAC1D","rank":"normal"}],"P27":[{"mainsnak":{"snaktype":"value","property":"P27","hash":"aaf0cb1e5ac19627a1093ee38d9f1d17011f99d9","datavalue":{"value":"10.1158/1078-0432.CCR-16-1125","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q100708$0F5E061B-797B-4059-A5C2-8E57F160A220","rank":"normal"}],"P43":[{"mainsnak":{"snaktype":"value","property":"P43","hash":"4a88f1913187130f514ffa34ed530c1094885d33","datavalue":{"value":"Daniel H. Li","type":"string"},"datatype":"string"},"type":"statement","id":"Q100708$F9A74626-2681-4EFE-99DF-F6B0284D897F","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P43","hash":"3ec1caff59b4287f1848d1a47001e290c59768ee","datavalue":{"value":"James B. Whitmore","type":"string"},"datatype":"string"},"type":"statement","id":"Q100708$8F36991A-9B56-4DA2-91D4-4C9D999B5767","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P43","hash":"49606c1b398839881dba31d2491fedf092dc5f45","datavalue":{"value":"Wentian Guo","type":"string"},"datatype":"string"},"type":"statement","id":"Q100708$DCE585C7-EAC4-406A-A3F5-7DCF12024A9A","rank":"normal"},{"mainsnak":{"snaktype":"value","property":"P43","hash":"24c66208f43f6659d48c83007d5d52ec29d84816","datavalue":{"value":"Yuan Ji","type":"string"},"datatype":"string"},"type":"statement","id":"Q100708$AB12AAA0-A153-4646-B7F2-58D2C3D7BACC","rank":"normal"}]},"sitelinks":{"mardi":{"site":"mardi","title":"Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials","badges":[]}}}}}